Article Details

Augmenta Bioworks and TFF Pharmaceuticals Announce Selection of Lead Monoclonal Antibody ...

Retrieved on: 2021-06-22 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Augmenta Bioworks and TFF Pharmaceuticals Announce Selection of Lead Monoclonal Antibody .... View article details on hiswai:

Excerpt

... lead monoclonal antibody for clinical development against COVID-19 under ... These antibodies will be developed utilizing TFF Pharmaceuticals' ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up